InsidersTradesSigma
Follow the 지아이이노베이션 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 지아이이노베이션 has recorded 18 public disclosures. Market capitalisation: €525.4bn. The latest transaction was reported on 13 July 2026 (Purchase). Among the most active insiders: 장명호. All data is free.
8
Insider Decl.
n/a
Thresholds
€118,077
4 ops.
Buy Volume
€97m
3 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 July 2026
Declarations18 total
Other
Other
Other
Other
Other
Other
Other
Other
Other
Other
18 of 18 declarations
About 지아이이노베이션
지아이이노베이션 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance healthcare.